Speaking at the World Economic Forum in Davos, Donald Trump said tariffs helped fix the long-time drug pricing scam in the US ...

Staying ahead of pharma supply challenges rests on anticipatory pillars and does not require reinventing the wheel, says ...

Logistics companies provide an essential service for clinical trials, but providers must be compliant with regulations. Learn ...

Pfizer has signed a deal worth up to $530m with US-based vaccine technology company Novavax. This agreement will see Pfizer ...

Bristol Myers Squibb (BMS) has entered into an agreement with Microsoft to advance AI-driven early lung cancer detection.

Novo Nordisk and Aspect Biosystems have started a new phase in their ongoing partnership focused on curative cellular ...

Dermatology in the near future will be characterized by digitally enabled, patient-centred research that reaches people where ...

GSK's RAPT Therapeutics acquisition will strengthen the former's immunology pipeline – specifically its offerings for food ...

DeepHow has launched PharmaCloud, a GMP-compliant cloud environment developed specifically to standardise AI-driven operator ...

Pfizer exits ViiV Healthcare with a $1.89bn payout, while GSK retains its majority stake amid the shareholder shake-up.

Despite lacklustre dealmaking, there were still trends identified from company presentations, such as pharma's upcoming ...

Regene Therapeutics has received RMAT designation from the US FDA for its lead product, NouvNeu001, aimed at treating PD.